Influenza Vaccine Uptake Among Patients with Inflammatory Bowel Disease: Comparable Outcomes Between Telemedicine and In-Person Care

Read full text Summarise with VIRAT
Authors: Mazen Almasry, Trevor L. Schell, Luke J. Richard, Francis A. Farraye, Mary S. Hayney, Freddy Caldera
Cited by: 0
References: 38

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Patients with inflammatory bowel disease (IBD) receiving immunosuppressive therapies are at increased risk of vaccine-preventable diseases, including influenza. Despite recommendations for annual influenza vaccination, uptake remains suboptimal. The COVID-19 pandemic prompted a surge in telemedicine (Tele-M) use, raising concerns about its impact on vaccination rates due to reduced in-person interactions. This study aimed to assess the impact of IBD-specific Tele-M on influenza vaccine uptake and identify predictors of vaccination in patients with IBD. Methods: This single-center retrospective study evaluated influenza vaccine uptake among adult patients with IBD seen between September 2021 and April 2022. Patients were categorized into two groups: Tele-M only and ≥1 in-person visit. Vaccination status was confirmed using the Wisconsin Immunization Registry. Primary outcome was influenza vaccination frequency by visit type, while secondary outcomes evaluated the impact of Tele-M on other vaccinations and predictors of influenza vaccine uptake. Results: = .11). The uptake of pneumococcal, hepatitis B, and zoster vaccines was also comparable. Predictors of higher influenza vaccine uptake included age ≥65, female sex, receipt of ≥3 COVID-19 vaccines, and previous influenza vaccination. Conclusions: IBD-specific Tele-M did not adversely affect influenza vaccine uptake among patients with IBD. These findings highlight the importance of ensuring vaccination compliance irrespective of healthcare delivery modes. Collaboration among healthcare providers is crucial to improve vaccination rates in patients with IBD.

Fields of Study & Subjects

Vaccine Coverage and Hesitancy Telemedicine and Telehealth Implementation Rheumatoid Arthritis Research and Therapies

Publication details

Journal / source
Crohn s & Colitis 360
Volume
8
Issue
2
Pages
otag022–otag022
Publication date
21 March 2026
Language
EN